Catherine Coste - 07 Dec 2023 Form 4 Insider Report for BIOMERICA INC (BMRA)

Role
Director
Signature
/s/ Catherine Coste
Issuer symbol
BMRA
Transactions as of
07 Dec 2023
Transactions value $
$0
Form type
4
Filing time
11 Dec 2023, 17:18:40 UTC
Previous filing
22 Nov 2023
Next filing
14 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding BMRA Common stock 43,790 07 Dec 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRA Non-qualified stock option Award +32,000 32,000 20 Apr 2023 Common Stock 32,000 $1.67 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options granted to Ms. Coste in April 2023 as part of her fiscal 2023 Board compensation package. Final issuance was subject to and conditioned upon the approval by stockholders of the 2023 Stock Incentive Plan, which occured on December 7, 2023.
F2 Not Applicable